Advanced Medical Optics Inc., Santa Ana, said Wednesday that the Food and Drug Administration approved its latest laser medical device to treat nearsighted patients with astigmatism.
Advanced Medical said the approval of its Star S4 IR excimer laser improved the company’s CustomVue procedure, which treats myopia and astigmatism.
The company said clinical trials found that 98% of patients who received the CustomVue nearsightedness treatment with the Star S4 IR had their vision corrected to 20/40 or better at six months. Some 84% were corrected to 20/20 vision or better without glasses or contact lenses.
The device maker acquired the Star S4 system through its acquisition of Santa Clara’s Visx Inc.
Advanced Medical shares were up 1.3% to $40.3 in trading Wednesday.
